Infanrix-IPV+Hib™
115389
Phase 3 mab completed
Quick answer
Infanrix-IPV+Hib™ for Acellular Pertussis is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Acellular Pertussis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed